whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported at an international research meeting in Fort Lauderdale, Florida.* The findings will also appear online in the leading journal Ophthalmology. Wet AMD is a common cause of loss of vision in older people. In the UK, around 70 per cent of people will experience severe loss of sight within two years of being diagnosed. To see more details visit, www.medicalnewstoday.com
